This document discusses drugs used to treat angina pectoris. It describes three main classes of drugs: organic nitrates, beta blockers, and calcium channel blockers. Organic nitrates work by dilating blood vessels to reduce preload and afterload on the heart. Beta blockers slow the heart rate and reduce contractility. Calcium channel blockers relax blood vessels to lower blood pressure and heart rate, reducing cardiac workload. The goals are to decrease oxygen demand on the heart muscle and bring more oxygen to it in order to relieve chest pain and prevent further heart issues.
Angina pectoris is the medical term for chest pain or discomfort due to coronary heart disease. It occurs when the heart muscle doesn't get as much blood as it needs. This usually happens because one or more of the heart's arteries is narrowed or blocked, also called ischemia.
Angina pectoris is the medical term for chest pain or discomfort due to coronary heart disease. It occurs when the heart muscle doesn't get as much blood as it needs. This usually happens because one or more of the heart's arteries is narrowed or blocked, also called ischemia.
Angina pectoris is chest pain or discomfort. A person may feel pain when insufficient oxygen-rich blood reaches the heart muscle. This reduced blood flow is caused by coronary heart disease (CHD), an accumulation of plaque inside the coronary blood vessels.
Myocardial Infarction Treatment
Classes of drugs used in the treatment of myocardial infarction
Vasodilators
General Pharmacology
Cardiac depressant drugs
Antiarrhythmics
Anti-thrombotics
Thrombolytics
Analgesics
General Mechanisms of Action
Angina pectoris is chest pain or discomfort. A person may feel pain when insufficient oxygen-rich blood reaches the heart muscle. This reduced blood flow is caused by coronary heart disease (CHD), an accumulation of plaque inside the coronary blood vessels.
Myocardial Infarction Treatment
Classes of drugs used in the treatment of myocardial infarction
Vasodilators
General Pharmacology
Cardiac depressant drugs
Antiarrhythmics
Anti-thrombotics
Thrombolytics
Analgesics
General Mechanisms of Action
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
We all have good and bad thoughts from time to time and situation to situation. We are bombarded daily with spiraling thoughts(both negative and positive) creating all-consuming feel , making us difficult to manage with associated suffering. Good thoughts are like our Mob Signal (Positive thought) amidst noise(negative thought) in the atmosphere. Negative thoughts like noise outweigh positive thoughts. These thoughts often create unwanted confusion, trouble, stress and frustration in our mind as well as chaos in our physical world. Negative thoughts are also known as “distorted thinking”.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
2. Physiology
All tissues and organs of the body are dependent on a
continuous arterial supply of oxygen and other vital
nutrients to support life and health.
With its high metabolic requirements, the heart is especially
demanding of a steady source of oxygen.
3. Preload and Afterload
Preload:
Preload, also known as the left ventricular end-diastolic pressure
(LVEDP), is the amount of ventricular stretch at the end of
diastole.
Think of it as the heart loading up for the next big squeeze of the
ventricles during systole.
Afterload:
Afterload, also known as the systemic vascular resistance (SVR),
is the amount of resistance the heart must overcome to open the
aortic valve and push the blood volume out into the systemic
circulation.
4. What will happen if Myocardium becomes
compromised of the oxygen supply ?
5. Angina pectoris
Angina pectoris is acute chest pain caused by
insufficient oxygen to a portion of the myocardium.
The classic presentation of angina pectoris is steady,
intense pain in the anterior chest, sometimes
accompanied by a crushing or constricting sensation.
6.
7. Angina: Goals of Pharmacologic
Management
The primary goal is to reduce the intensity and frequency
of angina episodes.
Additionally, successful pharmacotherapy should improve
exercise tolerance and allow the patient to actively
participate in activities of daily living.
Long-term goals include extending the patient’s life span
by preventing serious consequences of ischemic heart
disease such as dysrhythmias, HF, and MI.
8. Antianginal medications may be placed into two basic categories:
Those that terminate an acute angina episode in progress.
And those that decrease the frequency of angina episodes.
Antianginal drugs accomplish these goals by reducing the
myocardial demand for oxygen.
9. This may be accomplished by the following
mechanisms:
Slowing the heart rate.
Dilating veins so the heart receives less blood
(reduced preload).
Causing the heart to contract with less force
(reduced contractility).
Lowering blood pressure, thus offering the heart less
resistance when ejecting blood from its chambers
(reduced afterload).
10. Angina: Pharmacologic Management
The pharmacotherapy of angina consists of three classes of drugs:
Organic nitrates.
Rapid-acting organic nitrates are drugs of choice for terminating an
acute angina episode.
Long-acting nitrates, given by the oral or transdermal routes, are
effective alternatives for prophylaxis
Beta-adrenergic antagonists.
First-line drugs for preventing angina pain.
Calcium channel blockers.
Used when beta blockers are not tolerated well by a patient.
11. Angina: Pharmacologic Management
Ranolazine (Ranexa) is a newer drug for angina that is believed to
act by shifting the metabolism of cardiac muscle cells so that they
use glucose as the primary energy source rather than fatty acids.
This decreases the metabolic rate and oxygen demands of
myocardial cells.
Thus, this is the only antianginal that acts through its metabolic
effects, rather than hemodynamic effects.
It is used to prevent anginal episodes.
It will not terminate an acute attack.
The drug is approved only for chronic angina that has not
responded to other drugs.
12.
13. Organic Nitrates
The primary therapeutic action of the organic nitrates is their ability to
relax both arterial and venous smooth muscle.
Dilation of veins reduces the amount of blood returning to the heart
(preload), so the chambers contain a smaller volume.
With less blood for the ventricles to pump, cardiac output is reduced
and the workload on the heart is decreased, thereby lowering
myocardial oxygen demand.
The therapeutic outcome is that chest pain is alleviated and episodes
of angina become less frequent.
Organic nitrates also have the ability to dilate coronary arteries.
14. Organic Nitrates
This action, however, is crucial in treating vasospastic angina, in which
the chest pain is caused by coronary artery spasm.
The organic nitrates can relax these spasms, allowing more oxygen to
reach the myocardium, thereby terminating the pain.
The organic nitrates can relax these spasms, allowing more oxygen to
reach the myocardium, thereby terminating the pain.
Organic nitrates are of two types, short acting and long acting.
The short-acting nitrates, such as nitroglycerin, are taken sublingually
to quickly terminate an acute angina episode.
Long-acting nitrates, such as isosorbide dinitrate, are taken orally or
delivered through a transdermal patch to decrease the frequency and
severity of angina episodes.
18. Assessment
Obtain a complete health history including cardiovascular (including
previous MI, HF, valvular disease), cerebrovascular and neurologic
(including level of consciousness, history of stroke, head injury,
increased intracranial pressure), renal or hepatic dysfunction,
dysrhythmias, and pregnancy or lactation.
Obtain a drug history including allergies, current prescription and over-
the-counter (OTC) drugs, herbal preparations, and alcohol use.
Obtain baseline weight, vital signs (especially blood pressure [BP] and
pulse), and ECG. Assess for location and character of angina if
currently present.
19. Assessment throughout administration
Assess for desired therapeutic effects (e.g., chest pain has subsided
or has significantly lessened), heart rate and BP remain within
normal limits, and ECG remains within normal limits without signs of
ischemia or infarction.
Continue periodic monitoring of ECG for ischemia or infarction.
Continue frequent monitoring of BP and pulse whenever IV nitrates
are used or when giving rapid-acting (e.g., sublingual) nitrates. With
sublingual nitrates, take BP before and 5 minutes after giving the
dose and hold the drug if BP is less than 90/60, pulse is over 100, or
parameters as ordered, and consult with the health care provider
before continuing to give the drug.
20. Nursing Diagnosis
Decreased Cardiac Output.
Acute Pain.
Fatigue.
Activity Intolerance.
Deficient Knowledge (drug therapy).
Risk for Decreased Cardiac Tissue Perfusion, related to
adverse drug effects.
Risk for Falls, related to adverse drug effects.
Risk for Injury, related to adverse drug effects.
21. Nursing Interventions
Continue frequent assessments as above for therapeutic effects. (Because
nitrates cause vasodilation, preload and afterload diminish, decreasing
myocardial oxygenation needs, and chest pain diminishes).
Continue to monitor ECG, BP, and pulse. (Nitrates cause vasodilation and
possible hypotension. BP assessment aids in determining drug frequency and
dose. ECG monitoring helps detect adverse effects such as reflex tachycardia,
ischemia, or infarction).
For patients on transdermal nitroglycerin patches, remove the patch for 6–12
hours at night, or as directed by the health care provider. (Removing the patch
at night helps to prevent or delay the development of tolerance to nitrates.
Removing the patch at night, when cardiac workload is lessened, helps avoid
possible anginal attacks during the daytime when workload is greater.)
22. Beta Adrenergic Blockers
Beta-adrenergic antagonists or blockers reduce the cardiac workload
by slowing the heart rate and reducing contractility.
These drugs are as effective as the organic nitrates in decreasing the
frequency and severity of angina episodes caused by exertion.
Unlike the organic nitrates, tolerance does not develop to the
antianginal effects of the beta blockers.
They are ideal for patients who have both hypertension and CAD
because of their antihypertensive action.
Beta-adrenergic blockers are drugs of choice for the prophylaxis of
stable angina.
23. Beta Adrenergic Blockers
Not effective for treating vasospastic angina and may, in fact,
worsen this condition.
Side Effects
24.
25. Calcium Channel Blockers
Used for a number of cardiovascular conditions, including hypertension.
CCBs relax arteriolar smooth muscle, thus lowering BP.
This reduction in afterload decreases myocardial oxygen demand.
Some of the CCBs also slow conduction velocity through the heart,
decreasing heart rate and contributing to the reduced cardiac workload.
An additional effect of the CCBs is their ability to dilate the coronary
arteries and bring more oxygen to the myocardium.
This is especially important in patients with vasospastic angina.